Peer-Reviewed Publications
Here is the latest PMR and GCA research conducted and published by members of the AustPMRGCA team.
2025
-
Owen CE, Nakos O. Imaging findings in polymyalgia rheumatica. Rheumatology (Oxford). 2025 Mar 1;64(S1):i59-i63. doi: 10.1093/rheumatology/keae473.
-
Spiera RF, Devauchelle-Pensec V, Owen CE, Diaz-Gonzalez F, Takeuchi T, Drescher E, Anderson J, Arikan D, D'Cunha R, Parmentier J, Kruzikas DT, Zhao W, Yang Y, Stellpflug K, Buttgereit F. Efficacy, safety, pharmacokinetics, and immunogenicity of ABBV-154 in adults With glucocorticoid-dependent polymyalgia rheumatica: a phase 2, randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2025 Jan 27. doi: 10.1002/art.43129. Online ahead of print.
-
Leung JL, Deeble N, Yang V, Liew DFL, Buchanan RRC, Owen CE. Higher rates of depression in
polymyalgia rheumatica are strongly associated with poor physical function. J Clin Rheumatol. 2025 Mar 4. doi: 10.1097/RHU.0000000000002219. Online ahead of print. -
Nakos O, Poon AMT, Liew DFL, Owen CE. Mechanistic insights from a case of giant cell arteritis polymyalgia rheumatic spectrum disease. Int J Rheum Dis. 2025 Mar;28(3):e70064. doi: 10.1111/1756-185X.70064.
-
Leung JL, De Ross B, Gianoudis J, Deeble N, Yang V, Azzopardi R, Liew DFL, Daly RM, Buchanan RRC, Owen CE. More than pain and stiffness: persistent fatigue and sleep disturbance in polymyalgia rheumatica. J Rheumatol. 2025 Apr 15; jrheum.2024-0980.
2024
-
Owen CE, Poon AMT, Liu B, Liew DFL, Yap LP, Yang V, Leung JLY, McMaster C, Scott AM, Buchanan RRC. Characterising polymyalgia rheumatica on whole-body 18F-FDG PET/CT: an atlas. Rheumatol Adv Pract. 2024 Feb 8;1. doi: 10.1093/rap/rkae003.
-
Harris GK, Owen CE. A new dawn for polymyalgia rheumatica: from diagnosis to emerging treatments. Medicine Today. 2024;25(1-2):20-24.
-
Liew DFL, Owen CE. Treat-to-target in polymyalgia rheumatica and giant cell arteritis: an impending, multi-faceted challenge. Br J Rheumatol. 2024 Jan. doi: 10.1093/rheumatology/keae031.
-
Owen CE, Liew DFL. Subclinical giant cell arteritis in polymyalgia rheumatica: is vascular
imaging really ready to determine steroid dosing? Rheumatology (Oxford). 2024 Dec 1;62(12):3208-3210. doi: 10.1093/rheumatology/keae372. -
Bolhuis TE, Bosch P, Falzon L, Owen CE, Yates M, Mackie SL, van der Maas A, Dejaco C. Definitions of and instruments for disease activity, remission and relapse in polymyalgia rheumatica: a systematic literature review. Rheumatology (Oxford). 2025 Feb 1;64(2):455-469. doi: 10.1093/rheumatology/keae428.
2023
-
Liew DFL, Owen CE. Designing studies in newly diagnosed versus established polymyalgia rheumatica. Lancet Rheumatol. 2023 Dec 5;12:e701-e703. doi: 10.1016/S2665-9913(23)00294-1.
-
Leung JL, Twohig H, Muller S, Maxwell L, Mackie SL, Neill LM, Owen CE; OMERACT PMR Working Group. Test-retest reliability of pain VAS/NRS, stiffness VAS/NRS, HAQ-DI and mHAQ in polymyalgia rheumatica: An OMERACT study. Semin Arthritis Rheum. 2023 Jul 5;62:152239. doi: 10.1016/j.semarthrit.2023.152239. PMID: 37429139.
-
Owen CE, Yates M, Liew DFL, Poon AMT, Keen HI, Hill CL, Mackie SL. Imaging of giant cell arteritis - recent advances. Best Pract Res Clin Rheumatol. 2023 Jun 3:101827. doi: 10.1016/j.berh.2023.101827. PMID: 37277245.
-
Yang V, McMaster C, Owen CE, Leung JLY, Liu B, Buchanan RRC, Liew DFL. Better diagnostic tools needed for biopsy-negative giant cell arteritis. Lancet Rheumatol. 2023 Jan;5(1):e8-e10. doi: 10.1016/S2665-9913(22)00252-1.
2022
-
Hemmig AK, Gozzoli D, Werlen L, Ewald H, Aschwanden M, Blockmans D, Brouwer E, Buchanan RRC, Camellino D, Campochiaro C, Cimmino MA, Corominas H, Gloy V, Henckaerts L, Kyburz D, Moya-Alvarado P, Owen CE, Stegert M, Tomelleri A, van Sleen Y, Yamashita H, Imfeld S, Berger CT, Hemkens LG, Daikeler T. Subclinical giant cell arteritis in new onset polymyalgia rheumatica: A systematic review and meta-analysis of individual patient data. Semin Arthritis Rheum. 2022 Aug;55:152017. doi: 10.1016/j.semarthrit.2022.152017. Epub 2022 Apr 28. PMID: 35537222.
-
Bolhuis TE, Nizet LEA, Owen C, den Broeder AA, van den Ende CHM, van der Maas A. Measurement Properties of the Polymyalgia Rheumatica Activity Score: A Systematic Literature Review. J Rheumatol. 2022 Jun;49(6):627-634. doi: 10.3899/jrheum.211292. Epub 2022 Mar 1. PMID: 35232811.
2021
-
Mackie SL, Owen CE, Buchanan RRC, McGonagle D. A shared basis for overlapping immunopathologies in giant cell arteritis and polymyalgia rheumatica. Lancet Rheumatol. 2021 Dec;3(12):e826-e829. doi: 10.1016/S2665-9913(21)00361-1.
-
Yang V, McMaster C, Owen CE, Leung JL, Schachna L, Buchanan RRC, Liew DFL. Comment on: Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden-an update on incidence and first prevalence estimate. Rheumatology (Oxford). 2021 Nov 3;60(11):e421-e422. doi: 10.1093/rheumatology/keab558. PMID: 34264311.
-
Owen CE, McMaster C, Liew DFL, Leung JL, Scott AM, Buchanan RRC. Neutrophil to lymphocyte ratio predicts glucocorticoid resistance in polymyalgia rheumatica. Int J Rheum Dis. 2021 Jan;24(1):56-62. doi: 10.1111/1756-185X.14000. Epub 2020 Oct 12. PMID: 33043616.
2020
-
Owen CE, Poon AMT, Yang V, McMaster C, Lee ST, Liew DFL, Leung JL, Scott AM, Buchanan RRC. Abnormalities at three musculoskeletal sites on whole-body positron emission tomography/computed tomography can diagnose polymyalgia rheumatica with high sensitivity and specificity. Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2461-2468. doi: 10.1007/s00259-020-04731-z. Epub 2020 Feb 23. PMID: 32090280.
-
Twohig H, Owen C, Muller S, Mallen CD, Mitchell C, Hider S, Hill C, Shea B, Mackie SL. Outcomes Measured in Polymyalgia Rheumatica and Measurement Properties of Instruments Considered for the OMERACT Core Outcome Set: A Systematic Review. J Rheumatol. 2021 Jun;48(6):883-893. doi: 10.3899/jrheum.200248. Epub 2020 Aug 1. PMID: 32739892.
-
Yates M, Owen CE, Muller S, Graham K, Neill L, Twohig H, Boers M, Pujades Rodriguez M, Goodman SM, Cheah J, Dejaco C, Mukhtyar C, Nielsen BD, Robson J, Simon LS, Shea B, Mackie SL, Hill CL; OMERACT PMR Working Group. Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study. J Rheumatol. 2020 Sep 1;47(9):1379-1384. doi: 10.3899/jrheum.190575. Epub 2020 Feb 1. PMID: 32007937.
2019 and earlier
-
Owen CE, Liew DFL, Buchanan RRC. Musculotendinous Inflammation: The Defining Pathology of Polymyalgia Rheumatica? J Rheumatol. 2019 Dec;46(12):1552-1555. doi: 10.3899/jrheum.190367. PMID: 31787593.
-
Leung JL, Owen CE, Buchanan RRC, Liew DFL. Management of polymyalgia rheumatica in older people. J Pharm Pract Res. 2019 Sep;49(5):493-500. doi: 10.1002/jppr.1610.
-
Liew DFL, Owen CE, Buchanan RRC. Letter to the editor: Comments on 'A case of pembrolizumab-induced autoimmune haemolytic anaemia with polymyalgia rheumatica'. Eur J Cancer. 2019 Apr;111:59-60. doi: 10.1016/j.ejca.2018.11.034. Epub 2019 Feb 28. PMID: 30826657.
-
Owen CE, Yates M, Twohig H, Muller S, Neill LM, Harrison E, Shea B, Simon LS, Hill CL, Mackie SL. Toward a Core Outcome Measurement Set for Polymyalgia Rheumatica: Report from the OMERACT 2018 Special Interest Group. J Rheumatol. 2019 Oct;46(10):1360-1364. doi: 10.3899/jrheum.181050. Epub 2019 Feb 1. PMID: 30709960.
-
Liew DF, Owen CE, Buchanan RR. Prescribing for polymyalgia rheumatica. Aust Prescr. 2018 Feb;41(1):14-19. doi: 10.18773/austprescr.2018.001. Epub 2018 Feb 1. PMID: 29507455; PMCID: PMC5828929.
-
Owen CE, Poon AMT, Lee ST, Yap LP, Zwar RB, McMenamin CM, Lam SKL, Liew DFL, Pathmaraj K, Kemp A, Scott AM, Buchanan RRC. Fusion of positron emission tomography/computed tomography with magnetic resonance imaging reveals hamstring peritendonitis in polymyalgia rheumatica. Rheumatology (Oxford). 2018 Feb 1;57(2):345-353. doi: 10.1093/rheumatology/kex411. PMID: 29121248.
-
Owen CE, Buchanan RR, Hoi A. Recent advances in polymyalgia rheumatica. Intern Med J. 2015 Nov;45(11):1102-8. doi: 10.1111/imj.12823. PMID: 26036315.